Tag: Health Costs
Large Losses Anticipated for Primary Care Practices in 2020
Loss of gross revenue over 2020 due to COVID-19 estimated at $67,774 per full-time physician
COVID-19 Drug Remdesivir Could Cost Up to $3,120 Per Patient
In the U.S., government programs, additional Gilead assistance should mean all patients have access to the drug
Costs for COVID-19 High With Consumer-Directed Health Plans
Out-of-pocket costs high for consumer-directed health plan enrollees, especially younger individuals
Financial Hardship Linked to More ED Visits in Cancer Survivors
Medical financial hardship linked to lower uptake of influenza vaccine, lower breast cancer screening
Court Rules Against Drug Price Disclosures in TV Ads
Judges said HHS exceeded its legal authority by requiring drug price disclosure as part of its stewardship of Medicare, Medicaid
Four Months of Rifampin Costs Less Than Nine Months Isoniazid
Health system use and costs higher for nine months of isoniazid in adults and children in all settings
Considerable National Costs Attributed to Cancer Medical Care
Overall annualized average costs highest for end-of-life cancer phase followed by initial, continuing phases
Racial/Ethnic Disparities Seen in Economic Burden Due to Cancer Deaths
Non-Hispanic blacks have higher age-standardized PYLL, lost earning rates than whites for 13 of 19 sites
Inaccurate Provider Directories Can Lead to Out-of-Network Mental Health Care
Inaccuracies associated with use of out-of-network providers, surprise bills
New Medicare Benefit Would Limit Insulin Copays to $35 a Month
Benefit will be voluntary; Medicare recipients must pick an insurance plan that provides it
